Penbutolol is a lipophilic, nonselective beta-adrenergic receptor antagonist with anti-anginal and antihypertensive activities. Penbutolol competitively binds to and blocks beta-1 adrenergic receptors in the heart, thereby decreasing cardiac contractility and rate. This leads to a reduction in cardiac output and lowers blood pressure. In addition, penbutolol prevents the release of renin, a hormone secreted by the kidneys that causes constriction of blood vessels.
Penbutolol is a medication in the class of beta blockers, used in the treatment of high blood pressure. Penbutolol is able to bind to both beta-1 adrenergic receptors and beta-2 adrenergic receptors (the two subtypes), thus making it a non-selective β blocker. Penbutolol is a sympathomimetic drug with properties allowing it to act as a partial agonist at β adrenergic receptors. Penbutolol binds both beta-1 and beta-2 adrenergic receptors, rendering it a non-selective beta-blocker. Penbutolol can act as a partial agonist at beta-adrenergic receptors since it is a sympathomimetic drug. Penbutolol also demonstrates the high binding affinity to the 5-hydroxytryptamine receptor 1A with antagonistic effects.
Mechanism of Action of Penbutolol
Penbutolol acts on the β1 adrenergic receptors in both the heart and the kidney. When β1 receptors are activated by catecholamines, they stimulate a coupled G protein that leads to the conversion of adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP). The increase in cAMP leads to activation of protein kinase A (PKA), which alters the movement of calcium ions in the heart muscle and increases the heart rate. Penbutolol blocks the catecholamine activation of β1 adrenergic receptors and decreases heart rate, which lowers blood pressure.
Indications of Penbutolol
- Angina Pectoris Prophylaxis
- High Blood Pressure
- Angina pectoris
- Gastroesophageal variceal hemorrhage prophylaxis
- High blood pressure (Hypertension)
- Used in cardiovascular disease to treat arrhythmias,
- Nonvalvular atrial fibrillation
- Penbutolol is also indicated in the treatment of mild to moderate arterial hypertension. It may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. Penbutolol is contraindicated in patients with cardiogenic shock, sinus bradycardia, second and third-degree atrioventricular conduction block, bronchial asthma, and those with known hypersensitivity.
Contra-Indications of Penbutolol
- Diabetes
- Depression
- Myasthenia Gravis
- Complete Heart Block
- Partial Heart Block
- Sinus Bradycardia
- Suddenly serious symptoms of heart failure
- Occasional Numbness
- Tingling of Fingers and Toes
- Emphysema
- Asthma
- Severe Chronic Obstructed Lung Disease
- Liver problems
- Blood Circulation Failure due to Serious Heart Condition
- Anaphylactic Shock due to Allergy Shots
- Right-sided Heart Failure
- kidney disease with likely reduction in kidney function
- Allergies to beta-Blockers (Beta-Adrenergic Blocking Agents)
Dosage of Penbutolol
Strength: 20 mg
Hypertension
- Initial dose: 20 mg orally once a day.
- Maintenance dose: 20 to 40 mg orally once a day.
Angina Pectoris
- Initial dose: 20 mg orally once a day.
- Maintenance dose: 20 to 40 mg orally once a day.
Side Effects of Penbutolol
The most common
- Chest pain or discomfort
- a headache
- Blurred vision or other vision problems
- Fever, chills, or a sore throat
- Shortness of breath
- Slow or irregular heartbeat
- Dry mouth / a cough
- muscle trembling, jerking, or stiffness
- anxiety
- changes in vision, including blurred vision
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- stomach pain or cramping
- diarrhea
- stomach pain;
- back pain, joint or muscle pain.
- problems with your vision (including color vision);
- sudden chest pain or trouble breathing;
- pain or swelling in one or both legs;
- a migraine headache;
- pale skin, feeling light-headed or short of breath, rapid heart rate, trouble concentrating; or
More common
- Abdominal or stomach pain, discomfort, or tenderness
- chills or fever
- difficulty with moving
- a headache, severe and throbbing
- joint or back pain
- muscle aching or cramping
- muscle pains or stiffness
- chest pressure or squeezing pain in the chest
- discomfort in arms, shoulders, neck or upper back
- excessive sweating
- feeling of heaviness, pain, warmth and/or swelling in a leg or in the pelvis
- sudden tingling or coldness in an arm or leg
- sudden slow or difficult speech
- sudden drowsiness or need to sleep
- fast breathing
- sharp pain when taking a deep breath
- fast or slow heartbeat
- coughing up blood
- rust colored urine
- decreased amount of urine
Rare
- Anxiety
- change in vision
- chest pain or tightness
- confusion
- a cough
- Agitation
- arm, back, or jaw pain
- blurred vision
- chest pain or discomfort
- convulsions
- extra heartbeats
- fainting
- hallucinations
- a headache
- irritability
- lightheadedness
- mood or mental changes
- muscle pain or cramps
- muscle spasm or jerking of all extremities
- nervousness
Drug Interactions of Penbutolol
Penbutolol may interact with the following drug, supplements, & may change the efficacy of the drug
- alpha-1 blockers (e.g., doxazosin, prazosin, tamsulosin)
- alpha-2 blockers (e.g., clonidine, dexmedetomidine, methyldopa)
- angiotensin-converting enzyme inhibitors (ACEIs; e.g., captopril, ramipril)
- angiotensin II receptor blockers (i.e., irbesartan, losartan, valsartan)
- antipsychotics (e.g., clozapine, olanzapine, quetiapine, risperidone)
- atorvastatin
- azole antifungals (e.g., itraconazole, ketoconazole, posaconazole)
- barbiturates (e.g., phenobarbital)
- benzodiazepines (e.g., alprazolam, diazepam, lorazepam)
- beta-agonists (e.g., formoterol, salbutamol, salmeterol)
- calcium channel blockers (e.g., amlodipine, diltiazem, nifedipine, verapamil)
- carbamazepine
- cyclosporine
- dexamethasone
- diuretics (water pills; e.g., furosemide, hydrochlorothiazide)
- duloxetine
- lapatinib
- levodopa
- lidocaine
- MAO inhibitors (e.g., phenelzine, moclobemide, selegiline)
- macrolide antibiotics (e.g., azithromycin, clarithromycin, erythromycin)
- nilotinib
- nonsteroidal anti-inflammatory drugs (NSAIDs; e.g., ibuprofen, naproxen)
- other beta-blockers (e.g., atenolol, metoprolol, propranolol)
- pentoxifylline
- phosphodiesterase-5-inhibitors (e.g., sildenafil, tadalafil)
- sulfonylureas (e.g., gliclazide, glyburide, tolbutamide)
- sunitinib
- theophyllines (e.g., aminophylline, oxtriphylline, theophylline)
Pregnancy Catagory of Penbutolol
FDA Pregnancy Category C
Pregnancy
There are no reports of the use of penbutolol during pregnancy. As with other beta-blockers, it is recommended that newborns of mothers who were exposed to penbutolol near term or delivery be monitored for signs or symptoms of beta-blockade (bradycardia, hypotension, hypoglycemia) for at least 48 hours.
Lactation
Based on its physicochemical properties, penbutolol appears to present a low-risk to the breastfed infant. Because there is no published experience with penbutolol during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.
References
-
9d3b-3b00f655cbc2.xml
https://www.fda.gov/ForIndustry/DataStandards/StructuredProductLabeling/ucm162549.htm - https://www.webmd.com/drugs/2/drug-11467/Penbutolol/details/list-contraindications
- https://www.drugs.com/cdi/penbutolol.html
About the author